Contents of the presentation OST programme in SA region - Current scenario Scaling up OST in SA region Supply chain management.

Slides:



Advertisements
Similar presentations
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Advertisements

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Scaling Up HIV Prevention among IDUs in South Asia: the key issues & gaps Dr. M. Suresh Kumar MD DPM MPH Chennai India Inter-country Consultation on Preventing.
World Health Organization
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Project Steering Committee Meeting Colombo, 2012 RAS/H13: Prevention of transmission of HIV among drug users in SAARC countries.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Management of Medicines and Pharmaceutical Supplies for use in the prevention and treatment of Pre-eclampsia and Eclampsia Grace Adeya, SPS/MSH February.
Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.
Scale-up of OST services under the National AIDS Control Programme How is India doing it? WORKSHOP “OST in Developing Countries: A Primer” Atul Ambekar,
Participatory training techniques WORKSHOP “OST in Developing Countries: A Primer” Atul Ambekar, Alok Agrawal (India)
+ Opioid Substitution Therapy for Injecting Drug Users: Scale versus Quality WORKSHOP “OST in Developing Countries: A Primer” Atul Ambekar, Alok Agrawal.
Enhancing Institutional and Administrative Capacity case: POLAND
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
Opioid Substitution Therapy (OST) 1. Hierarchy of Harm Reduction If injecting, assistance to stop injecting drugs Never start using drugs Even if using.
By: Ms. Adelaida B. Roman Head, Network Support Component Regional Resource Centre for Asia and the Pacific Thailand.
Male’ Declaration Report on the progress since the Seventh Session of the Intergovernmental Meeting by Secretariat UNEP RRC.AP.
OPIOID SUBSTITUTION THERAPY
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
PROPOSAL FOR A MODEL MENTAL HEALTH COMMUNITY BASED SERVICE DELIVERY.
IDU TI Counsellor - Roles and Responsibilities
Essential package of targeted interventions for MARA Romania Experience.
Plan for Phase V of the Malé Declaration ( ) The Secretariat.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
Implementation of the Substitution Maintenance Therapy in the framework of the Programme “Overcoming HIV/AIDS Epidemics in Ukraine” Stakeholders meeting.
ACCESS TO MEDICINES - POLICY AND ISSUES
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Tajikistan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Current Status of HIV Pharmaceutical Management in Guangxi Province, China Helena Walkowiak, Management Sciences for Health /SPS Sharri Hollist, MSH/Strengthening.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM Presentation by Alvaro Bermejo and Andriy Klepikov at the Stakeholders Meeting.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
OVERVIEW OF THE ROLES OF VARIOUS INSTITUTIONS AND REGULATORY FRAMEWORK FOR AFLATOXIN CONTROL IN TANZANIA RAYMOND N. WIGENGE DIRECTOR OF FOOD SAFETY TFDA.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Malé Declaration Report on the Progress of. Malé Declaration: Phase IV Objectives Malé Declaration/IG11/2/1 1. Strengthen Regional Cooperation for addressing.
WBT in South Asia Dr.S.K.Roy Senior Scientist, ICDDR’B and Secretary, BBF.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Towards a National Alliance against Chronic Respiratory Diseases Nikolai Khaltaev, MD, PhD March 2006, GARD General Meeting, Beijing, China.
Understanding Monitoring & Indicators. What is Monitoring?  A continuing function that uses systematic collection of data on specified indicators to.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
HIV AND INFANT FEEDING A FRAMEWORK FOR PRIORITY ACTIONS.
HEALTH FINANCING MOH - HPG JAHR UPDATE ON POLICIES Eleventh Party Congress -Increase state investment while simultaneously mobilizing social mobilization.
Mental Health Care in Nepal: Current Situation and Challenges for Development of a District Mental Health Care Plan Nagendra P Luitel Transcultural Psychosocial.
REGIONAL PROJECT STEERING COMMITTEE MEETING “Prevention of Transmission of HIV among drug Users in SAARC Countries” Project RAS/H13 at Colombo, Sri Lanka.
Scaling-up harm reduction services towards universal access in Asia Models of good practice ICAAP IX Bali, Indonesia Nai Zindagi, Pakistan.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Presented by Nathalie Rose Social Worker PILS (Prevention Information Lutte contre le Sida) 5 August, 2008 IAC.
Recovery and Reconstruction in India: Future Directions
Fabienne Hariga Senior Adviser, HIV/AIDS Section
The analysis and advocacy (A2) project: Role in translating Thailand’s national AIDS strategy into provincial implementation plans S. Pantuwatana1, S.
Harm reduction: decriminalising drug use in Asia
Establishing the Infrastructure for Radiation Safety Preparatory Actions and Initial Regulatory Activities.
The role of the community in TB control
Operationalizing Export Certification and Regionalization Programmes
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

Contents of the presentation OST programme in SA region - Current scenario Scaling up OST in SA region Supply chain management

Contents of the presentation OST programme in SA region - Current scenario Scaling up OST in SA region Scaling up OST in SA region Supply chain management Supply chain management

OST in South Asia Region Bangladesh – Methadone India – Methadone, Buprenorphine Maldives – Methadone Nepal – Methadone, Buprenorphine COUNTRIES WITH OST Bhutan Pakistan Sri Lanka COUNTRIES WITHOUT OST

Existing OST models in SA region Different modalities of implementation – Setting ( Hospital / NGO / Hospital – NGO ) – Medications used ( Methadone / Buprenorphine ) – Activities/areas of OST implementation Linking clients to OST centre (outreach services) Assessment and dispensing (Clinic services) Psychosocial services

Bangladesh OST Programme Initiated in July 2010 in partnership with Ministry of Home through icddr,b Methadone as OST medicine One centre in Dhaka – Client load ~ 150

OST clinic Government hospital based clinic at the Drug treatment centre run by the Deptt of Narcotics Control, MoH Outreach, psychosocial and clinic services provided within one single setting Human resource: one medical doctor, 2 nurses, one counsellor, 8 outreach workers, one co-ordinator, 2 guards

India OST programme OST integrated in National AIDS Control Programme – Phase III Three models operational – Buprenorphine NGO based: 52 sites Government –NGO collaboration: 15 sites – Methadone Government hospital based: 5 sites piloted by UNODC

NGO OST clinic Run through NGOs implementing Harm reduction intervention programmes Clinic in the Drop-in-Centre located in the vicinity of the IDU hotspots Client load: 50 – 200 Human resource: Doctor, 2 nurses, one counsellor, 2 outreach workers

GO - NGO OST OST clinic located in Government hospital Client load: 50 – 200 Human resource: one doctor, 2 nurses, one counsellor, one data manager NGO Government hospital Outreach and follow up services provided by NGOs implementing Harm Reduction TI programmes Human resource: One outreach worker, one programme manager

MMT clinic Run through Government De-addiction Centres, run by Ministry of Health Referral of clients by NGOs working in the city/town Client load: 50 – 100 Human resource: one Doctor (part time), 2 nurses, one counsellor

Nepal OST Programme – Re-initiated in the year 2007, as an emergency response – Pilots in partnership with Ministry of Home – OST medicine: Methadone, ? Buprenorphine – Currently operational through 3 units

OST clinic located in Government hospital Client load: 100 – 150 Human resource: one doctor, 3 nurses, one counsellor, one data manager, 3 Guards NGO – SSU Government hospital Outreach, follow up and counselling services provided by Social Support Unit (SSU) managed by NGOs Human resource: 5 – 7 staff

Maldives Initiated in the year 2009 Partnership with nodal drug agency with the Ministry of Health OST medicine: Methadone One centre operational in Male`

OST clinic located in Government premises Client load: 70 Human resource: one doctor, 2 nurses, 3 counsellors NGOs Government hospital Outreach, follow up and part-counselling services provided by 3 NGOs Human resource: 3 – 5 staff

Contents of the presentation OST programme in SA region - Current scenario OST programme in SA region - Current scenario Scaling up OST in SA region Supply chain management Supply chain management

Scale-up: Considerations Setting the target – Universal access to HIV prevention services – 40% of IDUs to be covered with OST (Target setting guidelines, UNODC, UNAIDS, WHO, 2008) However…. – Current coverage is < 3% in any country of SA region – Different countries are in different stages of IDU-HIV epidemic – Coverage is largely limited to IDUs, and not to opioid dependent drug users

Following the epidemic – Estimate IDU from major districts/provinces – Shortlist provinces with significant IDU estimates – Identify provinces without OST services – Categorize provinces based on IDU estimates (high, medium and low priority) Prioritize provinces with moderate-high IDU-HIV prevalence

Choosing OST centres – Select models, medications based on in-country & regional experience – Shortlist potential centres – Conduct feasibility assessments Accessibility to the clients Infrastructure Safety measures for stock-keeping

Training and capacity building – Sensitisation meetings for policy makers (one day) – Trainings Induction trainings for core staff (5 days) Exposure visits/study tours Refresher trainings (3 days) – Develop in-country capacities – capacity building institutions Staff selection – Defining roles & responsibilities

Establish Quality assurance mechanism – Develop tools for standardisation of operation (Standard operating procedures, operational guidelines) – Regular monitoring and evaluation of the programme – Success determined by registration and retention of clients into the programme – Factors influencing quality Dose of medication Duration of treatment Staff attitude Satisfaction of clients

Costing – Current costing: range from USD – 180,000 USD Start up cost Sensitisation meeting Training programmes Feasibility assessment Refurbishment of centres Implementation cost Human resource Medical doctor Two nurses One counsellor Two outreach staff One data manager Accountant Other support staff Running cost - travel, communication Procurement cost Medication Buprenorphine: 37,000 USD Methadone: 8,000 USD Others: Dispensers, water, etc.

Contents of the presentation OST programme in SA region - Current scenario OST programme in SA region - Current scenario Scaling up OST in SA region Scaling up OST in SA region Supply chain management

International regulatory framework Different mechanism for narcotics / psychotropics – Methadone Covered under the 1961 convention Prior quota and annual consumption reporting required – Buprenorphine Covered under the 1971 convention Annual quota not required to be allocated Annual reporting for Buprenorphine (optional) Essential medicine list – WHO – Methadone and buprenorphine in the list

Laws / policies of countries Drawn in accordance to the conventions Most of the countries support the use of narcotics / psychotropics for medicine and scientific purpose – India: use of opioids for OST (de-addiction) mentioned under NDPS act – Nepal: harm reduction and OST endorsed in the National Drug policy

Supply chain mechanism Procurement Supply Stock management Replenishment of stocks

Procurement procedures 1.Determining the medicine required – Methadone: syrup in 5 or 10 mg/ml strengths – Buprenorphine tablets: 8 mg, 2 mg, 0.4 mg, 0.2 mg 2.Determining the quantity – No. of patients X no. of days X average dose per patient per day 3.Request for QUOTA Required only for Methadone Nodal Ministry requests INCB for a quota for Methadone [ Department of Narcotics Control (Bangladesh), Ministry of Home Affairs (Nepal), Central Bureau of Narcotics (India)]

Procuring agency – Each country has a nodal agency for procurement of goods and supplies Maldives  State Trading Organization Nepal  ‘Sajha’ trust – Negotiate rates with procuring agency (management cost) Invitation for bids – Invite International Competitive bids

Bidding agency – Must have a WHO-GMP certificate or equivalent certificate – For export, supplier would need “Certificate of Pharmaceutical Product”(COPP) as recommended by WHO Manufacturers / Distributors – Evidence of its technical, financial and production capability Finalise vendor – Technical and financial qualification Negotiate Rates

Establishing a supply chain mechanism Vendor Clinic Patient Vendor Central stock Clinic Patient SCENARIO ASCENARIO B

Stock management  Licenses from relevant authorities for storage and transport  Central stocks  Storage area of central stock  Responsible officer for central stock  Safe keeping: secure system  Flow of stocks from central to OST clinic  Chain of custody  Clinic stocks  Storage area  Secure system  Staff-in-charge?

Record maintenance for stock management Central stock register Inventory of the stock to be maintained Signed by the officer supplying the stock to clinic Clinic stock register Inventory of the stock to be maintained Signed by the officer receiving the stock in clinic Daily stock register Information on the daily stock transaction being made Dispensing register Total quantity of methadone dispensed in the clinic in the given day

Securing sustained supply: considerations  Clear understanding of the various Ministries/departments dealing with quota, licensing and procurement  Ensure clear commitment from the ministries – licensing, narcotics control / home  Ensure procurement is made well in-advance  Prepare a standard supply chain protocol / guideline

Securing sustained supply: considerations  Stock replenishment  Stock projection  Rotate stocks with eye on expiry dates  Establish a strong supply chain mechanism  Identify officers responsible in-charge of the stock at every point  Maintain records strictly  Check at regular intervals

Conclusion Opioid dependence is a chronic medical condition and requires long term therapy Different modalities followed in different countries for operationalising MMT Goal and objective of OST in each country – Treatment of opioid dependence – Prevention of HIV among opioid users, especially injecting drug users Urgent need to scale up OST in South Asia region

Advocacy for inclusion of narcotics / psychotropics in the national essential medicine list – Removal of import duties Use of computer based software for stock management (copy right issues, monopoly of pvt sector !) Robust supply chain an important part of scale up plan for OST Conclusion

THANK YOU